APA

Bruzzone M., Rubagotti A., Gadducci A., Catsafados E., Foglia G., Brunetti I., Giannessi P. G., Carnino F., Iskra L., Rosso R., Martoni A., Pannuti F., De Lisi V., Maltoni R., Ridolfi R., Mammoliti S., Gallo L., Boccardo F., Ragni N. & Conte P. F. (19970714). Intraperitoneal carboplatin with or without interferon-alpha in advanced ovarian cancer patients with minimal residual disease at second look: a prospective randomized trial of 111 patients. G.O.N.O. Gruppo Oncologic Nord Ovest. : Gynecologic oncology.

Chicago

Bruzzone M, Rubagotti A, Gadducci A, Catsafados E, Foglia G, Brunetti I, Giannessi P G, Carnino F, Iskra L, Rosso R, Martoni A, Pannuti F, De Lisi V, Maltoni R, Ridolfi R, Mammoliti S, Gallo L, Boccardo F, Ragni N and Conte P F. 19970714. Intraperitoneal carboplatin with or without interferon-alpha in advanced ovarian cancer patients with minimal residual disease at second look: a prospective randomized trial of 111 patients. G.O.N.O. Gruppo Oncologic Nord Ovest. : Gynecologic oncology.

Harvard

Bruzzone M., Rubagotti A., Gadducci A., Catsafados E., Foglia G., Brunetti I., Giannessi P. G., Carnino F., Iskra L., Rosso R., Martoni A., Pannuti F., De Lisi V., Maltoni R., Ridolfi R., Mammoliti S., Gallo L., Boccardo F., Ragni N. and Conte P. F. (19970714). Intraperitoneal carboplatin with or without interferon-alpha in advanced ovarian cancer patients with minimal residual disease at second look: a prospective randomized trial of 111 patients. G.O.N.O. Gruppo Oncologic Nord Ovest. : Gynecologic oncology.

MLA

Bruzzone M, Rubagotti A, Gadducci A, Catsafados E, Foglia G, Brunetti I, Giannessi P G, Carnino F, Iskra L, Rosso R, Martoni A, Pannuti F, De Lisi V, Maltoni R, Ridolfi R, Mammoliti S, Gallo L, Boccardo F, Ragni N and Conte P F. Intraperitoneal carboplatin with or without interferon-alpha in advanced ovarian cancer patients with minimal residual disease at second look: a prospective randomized trial of 111 patients. G.O.N.O. Gruppo Oncologic Nord Ovest. : Gynecologic oncology. 19970714.